Bestudy

Bestudy is a China-focused clinical development and regulatory solutions partner supporting biopharmaceutical and medical device companies across the full product lifecycle. The company delivers integrated Phase I–IV clinical trial services, including study design, regulatory submissions, site activation, clinical operations, data management, biostatistics, and medical and quality review. Bestudy also provides pharmacovigilance across clinical and post-marketing phases, as well as regulatory strategy and market entry support for global sponsors in China.
With strong local expertise and execution capabilities, Bestudy enables efficient and compliant development in China and multi-regional settings.
As of March 2026, Bestudy is part of the Syneos Health family of companies, expanding its ability to deliver globally integrated clinical and commercialization solutions.

Locations

  • APAC

Therapeutic Areas

  • Bone / Osteoporosis
  • Cardiovascular
  • Dermatology
  • Devices and Diagnostics
  • Diabetes
  • Gastroenterology
  • Hematology
  • Immunology
  • Infectious Diseases
  • Metabolic Diseases
  • Nephrology
  • Nutrition and Health
  • Oncology
  • Ophthalmology
  • Pain / Anesthesia
  • Psychiatry
  • Respiratory
  • Urology

Accreditations / Enablement

Partners are trained on the functionality of the Coder application, process optimization, and scope of Coder services. This Accreditation teaches Partners to integrate the medical coding solution with EDC studies and administer Coder segments. Coder Accreditation is dependent on the successful completion of the Rave EDC accreditation.
Partners are trained on the functionality of the electronic data capture (EDC) and clinical data management (CDM) system, process optimization exercises and scope of Medidata Rave services. This Accreditation teaches the staff to perform end user training, user and site administration, study build, reporting, outputs and amendment manager.